Chronic Obstructive Pulmonary Disease
Clinical research is centred on Chronic Obstructive Pulmonary Disease in a primary care setting, with attention to symptom burden, health status, and treatment selection in routine practice. The research interest includes patients with features suggestive of asthma overlap and elevated blood eosinophil counts.
- COPD symptom control
- Primary care management
- Asthma-like characteristics
- Blood eosinophils
The sponsor’s trial activity focuses on treatment choices used in everyday respiratory care, with emphasis on patients whose clinical profile may support different inhaled therapy options.
Inhaled Combination Therapy
Research interest extends to triple therapy and dual therapy for respiratory disease management, especially combinations involving ICS, LABA, and LAMA. The clinical focus is on comparative effectiveness in improving patient-reported outcomes.
- ICS/LABA/LAMA
- LABA/LAMA
- Inhaled corticosteroids
- Bronchodilator therapy
The therapeutic domain reflects interest in optimising inhaled regimens for symptomatic patients with COPD and related inflammatory features.
Respiratory Health Status
The sponsor’s research landscape includes assessment of health status and patient-reported respiratory outcomes, with use of the Clinical COPD Questionnaire as a measure of treatment impact. This places emphasis on daily symptom experience and functional well-being.
- Clinical COPD Questionnaire
- Patient-reported outcomes
- Symptomatic disease
- Quality of life
Interest in this area is directed toward understanding how respiratory therapies affect the lived burden of COPD in community-based care.
